PGY-2 Transplant Care Residency Program: University of Pittsburgh School of Pharmacy

PGY-2 Transplant Care


The transplantation/solid organ pharmacy residency at the University of Pittsburgh Medical Center (UPMC) is designed for the individual interested in developing specialized clinical expertise in pharmaceutical care for transplant patients. UPMC is the premier health system in western Pennsylvania, one of the most renowned academic medical centers in the United States, and a world leader in the field of transplantation. The transplantation pharmacy resident will gain expertise in the management of transplant patients in all phases of their care, from the intensive care unit to the ambulatory clinic. The resident will gain expertise in pathophysiology of disease leading to the need for organ transplantation, the management of immunosuppressive therapy, acute and chronic post-transplant complications, therapeutic drug monitoring, and management of drug interactions.

The resident will be integrally involved in research opportunities and education of students and other healthcare professionals. Through the Resident Research Series, the resident will identify a practice-related research project and mentor, learn about study design and implementation as well as complete a residency project suitable for publication. The Teaching Mastery Series allows residents to learn about various teaching methods as well as develop their skills as pharmacy educators and clinical preceptors. Many opportunities to present formal seminars, patient cases, journal clubs, and in-service education for UPMC staff occur throughout the year. The resident will gain experience in both didactic and experiential teaching and precepting at the University of Pittsburgh School of Pharmacy. Flexibility is provided to meet the individual resident's goals and objectives.

Program objectives include:

  1. Demonstrate proficiency, confidence, and compassion in providing direct patient care to transplant patients
  2. Demonstrate professionalism and effective communication skills in all components of pharmacy practice
  3. Optimize pharmacotherapy and safe medication practices
  4. Provide effective education to healthcare professionals
  5. Apply clinical and outcomes research concepts to professional practice

All residents must be eligible for pharmacist licensure in the Commonwealth of Pennsylvania. Applications for Pharmacist License and Intern Registration are available.

Application Process

Eligible candidates must have graduated from an accredited school of pharmacy and have completed or be on track to obtain successful completion of a PGY-1 pharmacy residency. The candidate must submit the standard application requirements via PhORCAS by December 31st. Standard requirements for an application include: demographics, academic history, transcript, curriculum vitae, letter of intent, extracurricular activities, and three standardized reference forms. Select candidates will be invited for an on-site interview and an on-site interview is required.

Reference guidance

We request a minimum of 3 references and ask that at least two of the three references comefrom preceptors with whom the applicant has worked in a direct patient care setting. The preceptor should be able to comment on the applicant’s responsibilities, patient workload, clinical problem-solving abilities, and time management skills. All reference writers must use the standard PhORCAS reference template and provide comments on a minimum of 7 of the 15 characteristics in the spaces provided.

This residency site agrees that no person at this site will solicit, accept, or use any ranking related information from any residency candidate.

Our purpose is to train graduates of the UPMC Presbyterian PGY2 Transplant Pharmacy Residency who are capable of providing comprehensive transplant pharmacy services, inpatient and ambulatory, for kidney, pancreas, liver, heart and lung transplant recipients. Furthermore, program graduates will be prepared to provide transplant-related education to patients and their families as well as teach current and future health care providers about pharmacy care for the transplant recipient.

Appointment Period: July 1 - June 30
Number Positions: 1
Starting Date: July 1
Salary: $49,055
Benefits: Health, dental, and eye care are provided free of charge. Life and disability are available. Vacation and professional travel provided.
Training Site Type: Hospital
Owner/Affiliates: Private
Model (type): Teaching, tertiary
Professional Staff: 48
Total Beds: 1093

Required Learning Experiences

  • Kidney Transplantation - Acute
  • Liver Transplantation - Acute
  • Lung Transplantation - Acute
  • Heart Transplantation - Acute/Ambulatory
  • Clinical Laboratory & Tissue Typing
  • Transplant Candidate Evaluation
  • Clinical Precepting

Required Longitudinal Learning Experiences

  • Hospital Pharmacy Operations
  • Presentation Skill Development
  • Resident Research
  • Multidisciplinary Committee

Select Elective Learning Experiences

  • Transplant ICU
  • Transplant Infectious Diseases
  • Research
  • Small bowel transplantation
  • Bone marrow transplantation

Other elective rotations are available based on resident interest and faculty availability.

Preceptors

Edward Horn, PharmD, BCCCP

Carlo Iasella, PharmD, MPH, BCPS

Heather Johnson, PharmD, BCPS

Catherine Kim, PharmD, BCPS, BCCCP

Erin McCreary, PharmD, BCPS, BCIDP

Cody Moore, PharmD, MPH, BCPS

Ryan Rivosecchi, PharmD, BCCCP

Lauren Sacha, PharmD, BCPS

Kristine Schonder, PharmD (Director)

Kristin Shimko, PharmD

Raman Venkataramanan, PhD

Adriana Zeevi, PhD

Sites

UPMC Presbyterian

Program Graduates

2017 – 2018
Moses Demehin, PharmD, BCPS
VCU Health, Richmond, VA

2016 – 2018 Clinical Trials and Outcomes Research in Transplant Fellow
Carlo Iasella, PharmD, MPH, BCPS
UPMC Presbyterian, Pittsburgh, PA

2016 – 2017
Olya Witkowsky, PharmD, BCPS
Ohio State University, Columbus, OH

2015 – 2017 Solid Organ Transplant Fellow
Cody Moore, PharmD, MPH, BCPS
UPMC Presbyterian, Pittsburgh, PA

2015 – 2016
Anh Vu, PharmD, BCPS
University of Kansas Hospital Center for Transplantation, Kansas City, KS2014

2014 – 2015
Alicia Lichvar, PharmD, BCPSU
UI Health – University of Illinois Hospital & Health Sciences System, Chicago, IL

2013 – 2014
Lauren Sacha, PharmD, BCPS
Saint Barnabas Medical Center, Livingston, NJ

2012 – 2013
Amanda Ingemi, PharmD
Sentara Healthcare, Norfolk, VA

2011 – 2012
Gretchen Kipp, PharmD, BCPS
UPMC Presbyterian, Pittsburgh, PA

2010 – 2011
David Johnson, PharmD, BCPS
Temple University Health System, Philadelphia, PA

2008 – 2009
Phyllis Chow, PharmD, MHA, BCPS
Seton Heart Specialty Care and Transplant Center, Austin, TX

Rivosecchi RM, Samanta P, DemehinM, Nguyen MH. Pharmacokinetics of azole antifungals in cystic fibrosis. Mycopathologia. 2018;183(1):139-50.

Witkowsky O, Teutenberg J, Althouse AD, Shullo M. Thrombotic events with proliferation signal inhibitor-based immunosuppression in cardiac transplantation. J Heart Lung Transplant 2019;38(6):619-26.

Ensor CR, Goehring KC, Iasella CJ, Moore CA, Lendermon EA, McDyer JF, Morrell MR, Sciortino CM, Venkataramanan R, Wiland AM. Belatacept for maintenance immunosuppression in cardiothoracic transplantation: the potential frontier.Clin Transplant 2018;31(10). doi: 10.1111/ctr.13363.

Cheng J, Moore CA, Iasella CJ, Glanville AR, Morrell MR, Smith RB, McDyer JF, Ensor CR. Clin Transplant 2018;32(5):doi: 10.1111/ctr.13235.

Ensor CR, Iasella CJ, Harrigan KM, Morrell MR, Moore CA, Shigemura N, Zeevi A, McDyer JF, Venkataramanan R. Increasing tacrolimus time-in-therapeutic range is associated with superior one-year outcomes in lung transplantrecipients. Am J Transplant. 2018;18(6):1527-1533.

Moore CA, Pilewski JM, Venkataramanan R, Robinson KM, Morrell MR, Wisniewski SR, Zeevi A, McDyer JF, Ensor CR. Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation. Transpl Infect Dis. 2017;19(3). doi: 10.1111/tid.12688.

Moore CA, Iasella CJ, Venkataramanan R, Lakkis FG, Smith RB, McDyer JF, Zeevi A, Ensor CR. Janus kinase inhibition for immunosuppression in solid organ transplantation: Is there a role in complex immunologic challenges? Hum Immunol. 2017;78(2):64-71. doi: 10.1016/j.humimm.2016.12.005.

Ensor CR, Rihtarchik LC, Morrell MR, Hayanga JW, Lichvar AA, Pilewski JM, Wisniewski S, Johnson BA, D’Cunha J, Zeevi A, McDyer JF. Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation. Clinical transplantation. 2017;31(4). doi:10.1111/ctr.12899.

Lichvar AA, Moore CA, Ensor CR, McDyer JF, Teuteberg JJ, Shullo MA. Evaluation of Direct Oral Anticoagulation Therapy in Heart and Lung Transplant Recipients. Progress in transplantation (Aliso Viejo, Calif.). 2016;26(3):263-9. doi:10.1177/1526924816661951.

Kalluri HV, Sacha LM, Ingemi AI, ShulloMA, Johnson HJ, Tevar AD, Humar A, Venkataramanan R. Low vitamin D exposure is associated with higher risk of infection in renal transplant recipients. Clin Transplant 2017;31(5): doi: 10.1111/ctr.12955.

Program Director

Kristine Schonder PharmD
Assistant Professor,
200 Lothrop Street
PFG 01-01-01
Pittsburgh, PA 15213
Phone: 412-864-3778
Fax: 412-864-3824
schonderks@upmc.edu

UPMC Presbyterian